Until recently, the inhibitory effect of HDAC1 has been proved in different types of cancer cells, including breast cancer, gastric cancer, pancreatic cancer, non-small cell lung cancer, and colon cancer. This evidence concerns the gene HDAC1 and breast carcinoma.